Boston Scientific Posts Strong Q4 and Full-Year 2024 Results
Boston Scientific Corporation (NYSE: BSX) released its Q4 and full-year 2024 financial report, showing robust...
Finanical Reports
Regeneron’s Q4 Financials Show 10% Revenue Growth, Driven by Eylea and Libtayo
US-based biopharmaceutical company Regeneron (NASDAQ: REGN) released its Q4 2024 financial report, showing revenues up...
AstraZeneca’s 2024 Financials Beat Expectations with 21% Revenue Growth
UK-based pharmaceutical giant AstraZeneca (AZ, NASDAQ: AZN) reported total revenues of USD 54.07 billion in...
Eli Lilly’s Q4 Sales Soar 45% to $13.53B on Strength of GLP-1 Drugs
Eli Lilly & Co. (NYSE: LLY) reported a robust finish to 2024, with Q4 revenues...
GSK Reports 7% Full-Year Sales Growth in 2024, Driven by Specialty Medicines
UK-based pharmaceutical giant GSK plc (NYSE: GSK) released its Q4 and full-year 2024 financial results,...
MSD Reports Strong Global Sales Growth in 2024, Despite China Challenges
US-based Merck, Sharp & Dohme Inc. (MSD, NYSE: MRK) released its Q4 2024 financial report,...
Amgen Reports Strong Q4 and Full-Year 2024 Sales Growth
Amgen (NASDAQ: AMGN) released its Q4 2024 financial results this week, reporting USD 33.42 billion...
Novo Nordisk Reports Soaring Global Sales in 2024, Driven by Diabetes and Obesity Care
Denmark’s Novo Nordisk (CPH: NOVO-B) reported this week that its global sales during 2024 reached...
AbbVie Reports Strong Q4 and Full-Year 2024 Financials
US-based pharmaceutical giant AbbVie (NYSE: ABBV) has released its Q4 and full-year 2024 financial results,...
Novartis Reports 12% YOY Growth in Full-Year Net Sales
Swiss pharmaceutical major Novartis (NYSE: NVS) has released its Q4 and full-year 2024 financial report,...
Takeda Reports 4.5% Revenue Growth in First Nine Months of Fiscal Year
Japan-headquartered Takeda (NYSE: TAK, TYO: 4502) has released its financial results for the 9-month period...
Daiichi Sankyo Reports 16.6% Revenue Growth in First Three Quarters of FY2024
Japan-based Daiichi Sankyo (TYO: 4568) has reported revenues of JPY 1.37 trillion ($8.927 billion) for...
Pfizer Reports 7% Revenue Growth in 2024, Expects Steady Performance in 2025
US major Pfizer Inc. (NYSE: PFE) has released its financial results for the fourth quarter...
Roche Reports 7% Growth in Full-Year Sales, Strength in Pharmaceuticals
Swiss pharmaceutical giant Roche (SWX: ROG) released its Q4 and full-year 2024 financials, reporting a...
Sanofi Reports Strong Q4 Growth, Plans EUR 5 Billion Share Buyback
French pharmaceutical giant Sanofi (NASDAQ: SNY) reported a strong fourth-quarter performance with 10.3% year-on-year (YOY)...
AbbVie’s 2024 Revenue Grows Despite Humira Decline, Skyrizi and Rinvoq Surge
US-based pharmaceutical giant AbbVie (NYSE: ABBV) reported its 2024 financial results on January 31, with...
Roche Reports 7% Revenue Growth in 2024, Driven by Oncology and Ophthalmology
Roche (SWX: ROG) released its 2024 annual financial report on January 30, showing a 7%...
Johnson & Johnson Reports Q4 Growth, Projects 2025 Sales Outlook
US-based Johnson & Johnson (J&J, NYSE: JNJ) has released its Q4 2024 financial results, reporting...
Abbott Labs Posts Q4 Growth, Projects Strong 2025 Outlook
US-based Abbott Laboratories (NYSE: ABT) has released its Q4 2024 financial results, reporting an 8.8%...
Junshi Biosciences Forecasts 29.71% Revenue Growth for 2024
China-based Shanghai Junshi Biosciences Co., Ltd (HKG: 1877, SHA: 688180) has released its 2024 annual...